The Research Institute at Nationwide Children's Hospital - K. John McLaughlin Profile
K. John McLaughlin
photo of K. John McLaughlin
Molecular and Human Genetics

PRINCIPAL INVESTIGATOR

John.McLaughlin@
nationwidechildrens.org


700 Children's Drive

Columbus, OH 43205
p: 614.722.2680

MCLAUGHLIN LABORATORY
Genomic imprinting refers to the phenomenon that, in somatic cells, certain genes are preferentially expressed from one parental allele, such that maternally and paternally inherited genetic information is expressed unequally.

We are interested in the consequences when imprinted gene expression patterns are disrupted, as this will lead to understanding as to why this unique gene control mechanism exists. We are using mouse models in which expression of imprinted genes is disturbed. One model is uniparental development including parthenogenesis and the paternal genome derived equivalent, androgenesis.

We are currently integrating our study of uniparental cells within the concept of generating autologous embryonic stem cells. Parthenogenetic embryos have been discussed as a source of patient matching embryonic stem cells. To validate this concept we are investigating the capacity of parthenogenetic stem cell derived cells (fetal and grown under certain conditions in vitro/in tissue culture), to replace adult bone marrow/hematopoiesis. Additionally we are also testing androgenetic embryonic stem cells, to increase the potential patient pool for a therapeutic approach based on uniparental cells. Biologically, this model can be used as a system to study the relevance of genomic imprinting in adult tissues.

An experimental strategy to investigate the ability of uniparental cells to engraft and differentiate in adults. Uniparental ES cells are injected into normal mouse blastocysts to generate composite fetuses (chimeras). Fetal liver cells from chimeras are then transplanted into lethally irradiated adults to reconstitute hematopoiesis.

Investigating both androgenetic and gynogenetic/parthenogenetic cells, we are differentiating (in vivo and in vitro) and transplanting uniparental cells to various tissues to determine the broader utility for tissue replacement therapy.

Web Site:: http://transgenicmousecore.nchresearch.org/